Demographic and clinical characteristics of patients during anti-VEGF intravitreal injection treatment
| Total eyes | 126 |
| Patients, n (%) | 126 |
| Female | 97 (77) |
| Male | 29 (33) |
| Age, mean±SD (years) | 79.5 (8.9) |
| Mean BCVA, mean±SD (ETDRS letters) | 63.7 (14.8) |
| Follow-up time, mean±SD (months) | 22.9 (13.5) |
| Previous anti-VEGF treatment, mean±SD, n | 10.4 (6.5) |
| IVI interval, mean±SD (months) | 2.35 (1.42) |
| CNV classification, n (%) | |
| Type 1 | 107 (85) |
| Type 2 | 21 (15) |
BCVA, Best Corrected Visual Acuity; CNV, choroidal neovascularisation; IVI, intravitreal injection; VEGF, vascular endothelial growth factor.